Skip to main content

Table 2 Perioperative data between two groups

From: Impact of type 2 diabetes mellitus on mid-term mortality for hypertrophic cardiomyopathy patients who underwent septal myectomy

VariableNo diabetes (n = 134)Diabetes (n = 67)p value
Concomitant procedures
 Mitral valve procedure, n22 (16.4%)9 (13.4%)0.58
 Tricuspid valvuloplasty, n15 (11.2%^)7 (10.4%)0.87
 CABG, n6 (4.5%)8 (11.9%)0.05
 Maze procedure, n5 (3.7%)8 (11.9%)0.03
 Cardiopulmonary bypass time, min107.6 ± 47.1113.3 ± 51.20.43
 Aortic crossclamping time, min72.7 ± 36.476.8 ± 35.90.45
 Postoperative ventilation time, min17.0 (13.0–21.0)17.0 (13.0–24.0)0.98
 Postoperative hospital stays, day8.4 ± 3.88.4 ± 4.20.96
 Post-operative LVOT gradient, mmHg6.6 ± 2.77.6 ± 3.40.04
 Perioperative death0 (0.0%)1 (1.5%)0.33
  1. Values are presented as percentage, mean ± SD, or median (interquartile range) when appropriate
  2. CABG coronary artery bypass graft, ICU intensive care unit